The Latest Breaking News from FDA

U.S. health officials have launched an inspection of a plant in Ecuador that made the cinnamon applesauce pouches linked to dozens of cases of acute lead poisoning in U.S. children

The global pharmaceutical market is witnessing robust growth, fueled by an escalating demand for healthcare services amid a burgeoning and aging population. Hence, fundamentally solid pharma stocks Novartis (NVS), Bristol-Myers Squibb (BMY), AbbVie (ABBV), and Taro Pharmaceutical (TARO) might be solid buys for gains this month. Read more.

Eli Lily’s Zepbound will undercut its rivals’ pricing but still costs over $1,000 a month.

One common decongestant, phenylephrine, was found ineffective this fall. Doctors are skeptical about the rest of the over-the-counter cold cures lineup.

Antiseizure drugs levetiracetam and clobazam can cause a serious hypersensitivity reaction called drug reactions with eosinophilia and systemic symptoms (DRESS), the FDA said.

Shares in Dutch medical device manufacturer Philips plunged Wednesday after the US Food and Drug Administration warned that its new machine to help patients sleep risked overheating.

The pharma industry’s long-term solid outlook is driven by steady demand for drugs due to the rising frequency of chronic conditions and growing geriatric population coupled with rapid technological innovations. Hence, quality pharma stocks, CytomX Therapeutics (CTMX), Eton Pharmaceuticals (ETON), and GSK (GSK), might be solid investments now for potential…

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.17%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.20%. Stock index futures this morning are under pressure on negative carryover from a decline in the Euro Stoxx 50 to a 1-week low. European stocks fell back...

Drugmakers shift reliance from China to India, benefiting Indian CDMOs. Western pharma companies are seeking to limit reliance on Chinese contractors, leading to increased interest in Indian CDMOs.